Russell B. Lingham

2.3k total citations
50 papers, 1.7k citations indexed

About

Russell B. Lingham is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Russell B. Lingham has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 16 papers in Pharmacology and 13 papers in Organic Chemistry. Recurrent topics in Russell B. Lingham's work include Microbial Natural Products and Biosynthesis (14 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and HIV/AIDS drug development and treatment (6 papers). Russell B. Lingham is often cited by papers focused on Microbial Natural Products and Biosynthesis (14 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and HIV/AIDS drug development and treatment (6 papers). Russell B. Lingham collaborates with scholars based in United States, Spain and Canada. Russell B. Lingham's co-authors include Sheo B. Singh, Keith C. Silverman, Deborah L. Zink, George M. Stancel, David S. Loose‐Mitchell, Gerald F. Bills, Michael Goetz, Peter J. Felock, Daria J. Hazuda and Rosalind G. Jenkins and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biochemistry.

In The Last Decade

Russell B. Lingham

50 papers receiving 1.6k citations

Peers

Russell B. Lingham

PHARM

ONCOL

BIOTE

Daishiro Ikeda Japan

Yasuhiro Hori Japan

Michizane Hashimoto Japan

Motohiro Hino Japan

Yukihiro Asami Japan

Tamio Mizukami Japan

TSUTOMU SAWA Japan

Klaus G. Steube Germany

YASUHISA TSURUMI Japan

Siew Bee Ng Singapore

Daishiro Ikeda Japan

Russell B. Lingham

1.1k ×1.4

660 ×1.1

PHARM

679 ×1.5

273 ×1.2

ONCOL

265 ×1.3

BIOTE

Citations per year, relative to Russell B. Lingham Russell B. Lingham (= 1×) peers Daishiro Ikeda

Countries citing papers authored by Russell B. Lingham

Since Specialization

Citations

This map shows the geographic impact of Russell B. Lingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell B. Lingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell B. Lingham more than expected).

Fields of papers citing papers by Russell B. Lingham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell B. Lingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell B. Lingham. The network helps show where Russell B. Lingham may publish in the future.

Co-authorship network of co-authors of Russell B. Lingham

This figure shows the co-authorship network connecting the top 25 collaborators of Russell B. Lingham. A scholar is included among the top collaborators of Russell B. Lingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell B. Lingham. Russell B. Lingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gordon, Renata E., Jennifer F. Nemeth, Sanjaya Singh, Russell B. Lingham, & Iqbal S. Grewal. (2020). Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics. Trends in biotechnology. 39(3). 298–310. 18 indexed citations

Hinke, Simon A., Thomas Kirchner, Katharine D’Aquino, et al.. (2018). Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody. Molecular Metabolism. 10. 87–99. 12 indexed citations

Tomkowicz, Brian, Eileen S. Walsh, Raluca Verona, et al.. (2015). TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway. PLoS ONE. 10(10). e0140694–e0140694. 57 indexed citations

Reger, Thomas S., Nicholas Stock, Bowei Wang, et al.. (2009). Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(3). 1173–1176. 7 indexed citations

Venkatraman, Shankar, Alec D. Lebsack, Michael F. Gardner, et al.. (2009). Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist. Bioorganic & Medicinal Chemistry Letters. 19(19). 5803–5806. 6 indexed citations

Venkatraman, Shankar, Jongwon Lim, Merryl Cramer, et al.. (2005). Influence of acid surrogates toward potency of VLA-4 antagonist. Bioorganic & Medicinal Chemistry Letters. 15(18). 4053–4056. 6 indexed citations

Singh, Sheo B., John G. Ondeyka, Carolyn L. Ruby, et al.. (2004). Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease. Biochemical and Biophysical Research Communications. 324(1). 108–113. 33 indexed citations

Singh, Sheo B., Deborah L. Zink, Gerald F. Bills, et al.. (2003). Four novel bis-(naphtho-γ-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase. Bioorganic & Medicinal Chemistry Letters. 13(4). 713–717. 37 indexed citations

Singh, Sheo B., et al.. (2000). Efficient syntheses, human and yeast farnesyl-protein transferase inhibitory activities of chaetomellic acids and analogues. Bioorganic & Medicinal Chemistry. 8(3). 571–580. 29 indexed citations

10.

Zhao, Annie, Rosalind G. Jenkins, Denis R. Patrick, et al.. (1999). Resorcylic Acid Lactones. Naturally Occurring Potent and Sclective Inbibitors.. The Journal of Antibiotics. 52(12). 1086–1094. 100 indexed citations

11.

Singh, Sheo B., Deborah L. Zink, Jon D. Polishook, et al.. (1998). Kampanols: novel ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis. Bioorganic & Medicinal Chemistry Letters. 8(16). 2071–2076. 34 indexed citations

12.

Silverman, Keith C., Hiranthi Jayasuriya, Carmen Cascales, et al.. (1997). Oreganic Acid, a Potent Inhibitor of Ras Farnesyl-Protein Transferase. Biochemical and Biophysical Research Communications. 232(2). 478–481. 13 indexed citations

13.

Jayasuriya, Hiranthi, Gerald F. Bills, Carmen Cascales, et al.. (1996). Oreganic acid: a potent novel inhibitor of ras farnesyl-protein transferase from an endophytic fungus. Bioorganic & Medicinal Chemistry Letters. 6(17). 2081–2084. 17 indexed citations

14.

Lingham, Russell B., Amy Hsu, J Sigmund, et al.. (1996). Quinoxapeptins: Novel Chromodepsipeptide Inhibitors of HIV-1 and HIV-2 Reverse Transcriptase. I. The Producing Organism and Biological Activity.. The Journal of Antibiotics. 49(3). 253–259. 45 indexed citations

15.

Jayasuriya, Hiranthi, Richard G. Ball, Deborah L. Zink, et al.. (1995). Barceloneic Acid A, a New Farnesyl-Protein Transferase Inhibitor from a Phoma Species. Journal of Natural Products. 58(7). 986–991. 40 indexed citations

16.

Singh, Sheo B., Jerrold M. Liesch, Russell B. Lingham, Michael Goetz, & W. Wayt Gibbs. (1994). Actinoplanic Acid A: A Macrocyclic Polycarboxylic Acid Which Is a Potent Inhibitor of Ras Farnesyl-Protein Transferase. Journal of the American Chemical Society. 116(25). 11606–11607. 18 indexed citations

17.

Doss, George A., et al.. (1993). Microbial Transformation of L-696, 474, a Novel Cytochalasin as an Inhibitor of HIV-1 Protease. Journal of Natural Products. 56(5). 755–761. 13 indexed citations

18.

Dombrowski, Anne W., Gerald F. Bills, Lawrence R. Koupal, et al.. (1992). L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. I. The producing organism and its fermentation.. The Journal of Antibiotics. 45(5). 671–678. 42 indexed citations

19.

Lingham, Russell B., Byron H. Arison, Amy Hsu, et al.. (1991). HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502. Biochemical and Biophysical Research Communications. 181(3). 1456–1461. 5 indexed citations

20.

Lingham, Russell B., George M. Stancel, & David S. Loose‐Mitchell. (1988). Estrogen Regulation of Epidermal Growth Factor Receptor Messenger Ribonucleic Acid. Molecular Endocrinology. 2(3). 230–235. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact